Original article
Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU)
Perfil clínico de los pacientes tratados con evolocumab en unidades de lípidos/medicina interna en España. Estudio observacional (RETOSS-IMU)
Lluís Masanaa,
, José López Mirandab, Fernando Civeirac, Leonardo Reinaresd, Carlos Guijarroe, Núria Planaa, Rafael Cuencaf, Demetrio Sánchezg, José Luis Hernándezh, Raimundo Andrési, Agustín Blancoj, Santiago Villamayork
Corresponding author
a Servicio de Medicina Interna, Hospital Universitario Sant Joan, IISPV, CIBERDEM, Reus, Tarragona, Spain
b Servicio de Medicina Interna, Hospital Universitario Reina Sofía, IMIBIC, Universidad de Córdoba, CIBEROBN, Córdoba, Spain
c Servicio de Medicina Interna, Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Universidad de Zaragoza, Zaragoza, Spain
d Servicio de Medicina Interna, Hospital Clínico San Carlos, Madrid, Spain
e Servicio de Medicina Interna, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain
f Servicio de Medicina Interna, Hospital Alto Guadalquivir, Andújar, Jaén, Spain
g Servicio de Medicina Interna, Hospital Nuestra Señora de Sonsoles, Ávila, Spain
h Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Hospital Universitario Marqués de Valdecilla-IDIVAL. Santander. Universidad de Cantabria, Santander, Spain
i Servicio de Medicina Interna, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
j Servicio de Medicina Interna, Hospital Universitario 12 de Octubre, Madrid, Spain
k Departamento Médico, Amgen S.A., Barcelona, Spain
Ver másRead
2273
Timeswas read the article
501
Total PDF
1772
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 21 | 3 | 24 |
| 2025 11 | 92 | 35 | 127 |
| 2025 10 | 73 | 17 | 90 |
| 2025 9 | 61 | 31 | 92 |
| 2025 8 | 60 | 15 | 75 |
| 2025 7 | 74 | 12 | 86 |
| 2025 6 | 40 | 5 | 45 |
| 2025 5 | 56 | 8 | 64 |
| 2025 4 | 58 | 4 | 62 |
| 2025 3 | 48 | 9 | 57 |
| 2025 2 | 57 | 8 | 65 |
| 2025 1 | 35 | 4 | 39 |
| 2024 12 | 26 | 4 | 30 |
| 2024 11 | 35 | 5 | 40 |
| 2024 10 | 38 | 9 | 47 |
| 2024 9 | 40 | 20 | 60 |
| 2024 8 | 25 | 14 | 39 |
| 2024 7 | 13 | 6 | 19 |
| 2024 6 | 9 | 4 | 13 |
| 2024 5 | 18 | 3 | 21 |
| 2024 4 | 48 | 4 | 52 |
| 2024 3 | 155 | 9 | 164 |
| 2024 2 | 11 | 9 | 20 |
| 2024 1 | 15 | 8 | 23 |
| 2023 12 | 32 | 22 | 54 |
| 2023 11 | 32 | 10 | 42 |
| 2023 10 | 26 | 5 | 31 |
| 2023 9 | 32 | 10 | 42 |
| 2023 8 | 16 | 5 | 21 |
| 2023 7 | 17 | 8 | 25 |
| 2023 6 | 19 | 7 | 26 |
| 2023 5 | 11 | 12 | 23 |
| 2023 4 | 19 | 7 | 26 |
| 2023 3 | 17 | 4 | 21 |
| 2023 2 | 15 | 5 | 20 |
| 2023 1 | 15 | 4 | 19 |
| 2022 12 | 19 | 7 | 26 |
| 2022 11 | 18 | 13 | 31 |
| 2022 10 | 21 | 14 | 35 |
| 2022 9 | 27 | 6 | 33 |
| 2022 8 | 24 | 5 | 29 |
| 2022 7 | 19 | 7 | 26 |
| 2022 6 | 13 | 5 | 18 |
| 2022 5 | 21 | 7 | 28 |
| 2022 4 | 19 | 12 | 31 |
| 2022 3 | 14 | 14 | 28 |
| 2022 2 | 18 | 2 | 20 |
| 2022 1 | 33 | 4 | 37 |
| 2021 12 | 20 | 6 | 26 |
| 2021 11 | 20 | 8 | 28 |
| 2021 10 | 25 | 9 | 34 |
| 2021 9 | 12 | 9 | 21 |
| 2021 8 | 12 | 3 | 15 |
| 2021 7 | 12 | 4 | 16 |
| 2021 6 | 20 | 1 | 21 |
| 2021 5 | 17 | 5 | 22 |
| 2021 4 | 18 | 6 | 24 |
| 2021 3 | 10 | 7 | 17 |
| 2020 11 | 1 | 2 | 3 |
Show all